The global digital therapeutics market has been experiencing steady growth in recent years. With the increasing prevalence of chronic diseases and rising healthcare costs, digital therapeutics have emerged as a promising solution for improving patient outcomes and reducing healthcare expenditures.
Digital therapeutics refer to evidence-based therapeutic interventions that are delivered through digital or mobile platforms. These interventions use software, devices, or other technology to treat, manage, or prevent a range of medical conditions, including diabetes, obesity, cardiovascular disease, and mental health disorders.
The global digital therapeutics market is expected to reach a value of USD 11.82 billion by 2028, growing at a CAGR of 22.7% from 2021 to 2028. The market is driven by several factors, including the increasing prevalence of chronic diseases, the growing need for remote patient monitoring and management, and the rising adoption of digital health technologies.
One of the key drivers of the digital therapeutics market is the increasing prevalence of chronic diseases. According to the World Health Organization, chronic diseases are responsible for 70% of all deaths globally. The burden of chronic diseases is expected to continue to rise in the coming years, due to factors such as an aging population and unhealthy lifestyle habits. Digital therapeutics have the potential to improve outcomes for patients with chronic diseases by providing personalized, accessible, and cost-effective care.
Another factor driving the growth of the digital therapeutics market is the growing need for remote patient monitoring and management. Digital therapeutics can provide real-time data on patient health, allowing healthcare providers to monitor patients remotely and intervene when necessary. This is particularly important in the current healthcare landscape, where there is a shortage of healthcare providers and an increasing demand for virtual care.
The rising adoption of digital health technologies is also contributing to the growth of the digital therapeutics market. Consumers are increasingly using digital health apps and wearables to track their health and wellness, and healthcare providers are incorporating these technologies into their practice to improve patient care. Digital therapeutics offer a new way to deliver healthcare that is convenient, personalized, and accessible.
In conclusion, the global digital therapeutics market is expected to continue to grow in the coming years, driven by factors such as the increasing prevalence of chronic diseases, the growing need for remote patient monitoring and management, and the rising adoption of digital health technologies. As digital therapeutics continue to gain acceptance, they have the potential to revolutionize healthcare delivery and improve outcomes for patients worldwide.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Everest Market Insights journalist was involved in the writing and production of this article.